• Aptevo Therapeutics will hold a virtual special shareholder meeting on Sept. 22, 2026.
• Shareholders will vote on an amended and restated certificate of incorporation with technical and administrative updates.
• A proposal seeks approval for potential issuance of common stock tied to Inducement Warrants and Common Warrants from an Aug. 12, 2026 financing.
• Investors will also decide on the Fifth Amended and Restated 2018 Stock Incentive Plan, including 180,000 additional shares for equity awards.
• An adjournment authorization is on the ballot to allow additional solicitation if votes are insufficient on key items.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-361119), on August 21, 2026, and is solely responsible for the information contained therein.